Literature DB >> 28357177

Pancreatic neuroendocrine tumors.

Jian Sun1.   

Abstract

Pancreatic neuroendocrine neoplasms (pNENs) are a heterogeneous group of tumors including well differentiated pancreatic neuroendocrine tumors (pNETs) and neuroendocrine carcinomas (pNECs). The incidence of pNENs has increased over the past few decades. Although, the understanding and interest for this tumor have also increased significantly, the debate about classification and diagnosis continues. Although the primary treatment for pNENs is surgical resection, there is still a lack of effective therapeutic options for patients with advanced unresectable pNENs. Although many therapeutic methods have proven effective, the choice of treatment and specific programs are still unclear. Our article presents an overview of pNENs, with a focus on their diagnostic work-up, clinical presentation and treatment options.

Entities:  

Keywords:  Pancreatic neuroendocrine neoplasms; diagnosis; prognosis; surgery

Year:  2017        PMID: 28357177      PMCID: PMC5359348          DOI: 10.5582/irdr.2017.01007

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  66 in total

1.  The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.

Authors:  Olca Basturk; Zhaohai Yang; Laura H Tang; Ralph H Hruban; Volkan Adsay; Chad M McCall; Alyssa M Krasinskas; Kee-Taek Jang; Wendy L Frankel; Serdar Balci; Carlie Sigel; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

2.  Sequencing and combining systemic therapies for pancreatic neuroendocrine tumors.

Authors:  Matthew H Kulke
Journal:  J Clin Oncol       Date:  2015-04-13       Impact factor: 44.544

3.  Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.

Authors:  Ewa Pomianowska; Ivar P Gladhaug; Krzysztof Grzyb; Bård I Røsok; Bjørn Edwin; Deidi S Bergestuen; Oystein Mathisen
Journal:  Scand J Gastroenterol       Date:  2010-08       Impact factor: 2.423

Review 4.  Imaging of neuroendocrine tumors of the pancreas.

Authors:  C Dromain; D Déandréis; J-Y Scoazec; D Goere; M Ducreux; E Baudin; L Tselikas
Journal:  Diagn Interv Imaging       Date:  2016-11-18       Impact factor: 4.026

Review 5.  Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  Amareshwar Chiruvella; David A Kooby
Journal:  Surg Oncol Clin N Am       Date:  2016-04       Impact factor: 3.495

6.  Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.

Authors:  Samira M Sadowski; Vladimir Neychev; Corina Millo; Joanna Shih; Naris Nilubol; Peter Herscovitch; Karel Pacak; Stephen J Marx; Electron Kebebew
Journal:  J Clin Oncol       Date:  2015-12-28       Impact factor: 44.544

Review 7.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

8.  Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.

Authors:  Karl Y Bilimoria; Mark S Talamonti; James S Tomlinson; Andrew K Stewart; David P Winchester; Clifford Y Ko; David J Bentrem
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

9.  Are G3 ENETS neuroendocrine neoplasms heterogeneous?

Authors:  Fritz-Line Vélayoudom-Céphise; Pierre Duvillard; Lydia Foucan; Julien Hadoux; Cecile N Chougnet; Sophie Leboulleux; David Malka; Joël Guigay; Diane Goere; Thierry Debaere; Caroline Caramella; Martin Schlumberger; David Planchard; Dominique Elias; Michel Ducreux; Jean-Yves Scoazec; Eric Baudin
Journal:  Endocr Relat Cancer       Date:  2013-08-19       Impact factor: 5.678

10.  Population-based study of islet cell carcinoma.

Authors:  James C Yao; Milton P Eisner; Colleen Leary; Cecile Dagohoy; Alexandria Phan; Asif Rashid; Manal Hassan; Douglas B Evans
Journal:  Ann Surg Oncol       Date:  2007-09-26       Impact factor: 5.344

View more
  11 in total

1.  Long non-coding RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and SNHG9 are novel prognostic markers for pancreatic cancer.

Authors:  Baogang Zhang; Changfeng Li; Zhixia Sun
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.

Authors:  James Saller; Shabnam Seydafkan; Mohammad Shahid; Manoj Gadara; Mauro Cives; Steven A Eschrich; David Boulware; Jonathan R Strosberg; Nasir Aejaz; Domenico Coppola
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

Review 3.  Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.

Authors:  Chandra K Maharjan; Po Hien Ear; Catherine G Tran; James R Howe; Chandrikha Chandrasekharan; Dawn E Quelle
Journal:  Cancers (Basel)       Date:  2021-10-12       Impact factor: 6.639

4.  68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours.

Authors:  P Mapelli; C Bezzi; D Palumbo; C Canevari; S Ghezzo; A M Samanes Gajate; B Catalfamo; A Messina; L Presotto; A Guarnaccia; V Bettinardi; F Muffatti; V Andreasi; M Schiavo Lena; L Gianolli; S Partelli; M Falconi; P Scifo; F De Cobelli; M Picchio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-14       Impact factor: 10.057

Review 5.  A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.

Authors:  Jiayun M Fang; Jiaqi Shi
Journal:  Arch Pathol Lab Med       Date:  2019-09-11       Impact factor: 5.534

6.  RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo.

Authors:  Chandra K Maharjan; Shaikamjad Umesalma; Courtney A Kaemmer; Viviane P Muniz; Casey Bauchle; Sarah L Mott; K D Zamba; Patrick Breheny; Mariah R Leidinger; Benjamin W Darbro; Samuel B Stephens; David K Meyerholz; Dawn E Quelle
Journal:  Biomedicines       Date:  2021-06-02

7.  A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.

Authors:  Yong Gao; Hao Gao; Guangfu Wang; Lingdi Yin; Wenbin Xu; Yunpeng Peng; Junli Wu; Kuirong Jiang; Yi Miao
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

8.  Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms.

Authors:  Shengming Deng; Zhiyao Fan; Huanyu Xia; Yitao Gong; Yunzhen Qian; Qiuyi Huang; He Cheng; Kaizhou Jin; Zhiwen Xiao; Guopei Luo; Xianjun Yu; Chen Liu
Journal:  Cancer Manag Res       Date:  2021-01-08       Impact factor: 3.989

Review 9.  Imaging presentation of pancreatic neuroendocrine neoplasms.

Authors:  Valentina Ciaravino; Riccardo De Robertis; Paolo Tinazzi Martini; Nicolò Cardobi; Sara Cingarlini; Antonio Amodio; Luca Landoni; Paola Capelli; Mirko D'Onofrio
Journal:  Insights Imaging       Date:  2018-10-09

10.  Ampullary Adenocarcinoma with Incidental Pancreatic Neuroendocrine Tumor: Report of an Extremely Rare Case and Review of Literature.

Authors:  Matteo Viti; Pietro Maria Lombardi; Mattia Marinelli; Monica Onorati; Corrado D'Urbano
Journal:  Cureus       Date:  2019-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.